IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 12 February 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01579-06v1
75/4/1586    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marks, M.
Right arrow Articles by Pirofski, L.-a.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, M.
Right arrow Articles by Pirofski, L.-a.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01579-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

THE INFLUENCE OF NEUTROPENIA ON THE COURSE OF SEROTYPE 8 PNEUMOCOCCAL PNEUMONIA IN MICE

Matthew Marks, Tamika Burns, Maria Abadi, Beza Seyoum, Justin Thornton, Elaine Tuomanen, and Liise-anne Pirofski*

Division of Infectious Diseases, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York; Department of Pathology, Albert Einstein College of Medicine and Jacobi Medical Center, Bronx, New York; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee

* To whom correspondence should be addressed. Email: Pirofski{at}aecom.yu.edu.


   Abstract

Polymorphoneutrophils (PMNs) are important effector cells in host defense against pneumonia. However, PMNs can also induce inflammation and tissue damage. To investigate the contribution of PMNs to host defense against pneumococcal pneumonia, we determined the effect of the PMN depleting rat MAb RB6-8C5 on the survival and the inflammatory and cellular response in the lungs to a lethal intranasal infection with serotype 8 pneumococcus in Balb/c mice. Control mice received rat IgG (rIgG). Strikingly, the survival of RB6-treated mice was significantly prolonged compared to rIgG-treated mice. Although the number of lung CFUs was statistically similar in both groups 4, 24 and 32 hrs after infection, rIgG-treated mice developed higher levels of bacteremia and histopathological examination of the lungs of infected mice revealed marked differences between RB6- and rIgG-treated mice. RB6-treated mice had focal, perivascular lesions without accompanying parenchymal inflammation and rIgG-treated mice had diffuse, interstitial parenchymal inflammation. Lung homogenates from the rIgG-treated mice had more leukocytes and significantly more total and apoptotic PMNs as determined by FACS analysis with Annexin V and TUNEL staining of lung tissue samples. Studies with a pneumolysin deficient mutant of the serotype 8 strain we used also demonstrated prolonged survival of RB6- compared to rIgG-treated mice. Taken together, our findings suggest that PMNs enhance the likelihood of early death and alter the pathological response to pneumococcal lung infection in Balb/c mice with serotype 8 pneumonia without significantly affecting bacterial clearance or the cytokine response.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.